Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study

INTRODUCTION: Stereotactic MR-guided adaptive radiotherapy (SMART) is an attractive modality of radiotherapy for pancreatic tumors. The objectives of this prospective registry study were to report the dosimetric benefits of daily adaptation of SMART and the first clinical results in pancreatic tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalet, Morgan, Bordeau, Karl, Cantaloube, Marie, Valdenaire, Simon, Debuire, Pierre, Simeon, Sebastien, Portales, Fabienne, Draghici, Roxana, Ychou, Marc, Assenat, Eric, Dupuy, Marie, Gourgou, Sophie, Colombo, Pierre-Emmanuel, Carrere, Sebastien, Souche, François-Regis, Aillères, Norbert, Fenoglietto, Pascal, Azria, David, Riou, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959839/
https://www.ncbi.nlm.nih.gov/pubmed/35356227
http://dx.doi.org/10.3389/fonc.2022.842402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959839/
https://www.ncbi.nlm.nih.gov/pubmed/35356227
http://dx.doi.org/10.3389/fonc.2022.842402

Ejemplares similares